Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

102.50 +0.15 (+0.15%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
News headline image
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics ↗
Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum. 
Via Benzinga
News headline image
EXAS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Exact Sciences Corporation is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Abbott To Acquire Exact Sciences For Up To $23B ↗
Under the deal, Exact Sciences shareholders will receive $105 per common share in cash. 
Via Stocktwits
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover ↗
Via Stocktwits
News headline image
Why Exact Sciences Stock Blasted Nearly 24% Higher Today ↗
A strategic investor is reportedly in advanced talks to purchase the company. 
Via The Motley Fool
News headline image
Earnings Scheduled For November 3, 2025 ↗
 
Via Benzinga
News headline image
Earnings Preview: Exact Sciences ↗
 
Via Benzinga
News headline image
2 Surging Stocks with Competitive Advantages and 1 We Question
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
News headline image
Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome’s Blood-Based Colorectal Cancer Screening Tests
From Exact Sciences Corp.
Via Business Wire
News headline image
The 5 Most Interesting Analyst Questions From Exact Sciences’s Q3 Earnings Call
Exact Sciences’ third quarter results received a positive response from the market, reflecting strong revenue growth and robust execution in its core screening business. Management attributed the... 
Via StockStory
Topics Earnings
News headline image
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗
These companies are slowly coming into their own. 
Via The Motley Fool
News headline image
Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test
From Exact Sciences Corp.
Via Business Wire
News headline image
Why Exact Sciences Stock Blasted Higher on Tuesday ↗
An impressive beat-and-raise third quarter made the company a standout that day. 
Via The Motley Fool
News headline image
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results ↗
 
Via Benzinga
News headline image
Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday? ↗
Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date... 
Via Benzinga
News headline image
Amazon To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year... 
Via StockStory
News headline image
Exact Sciences to Participate in November Investor Conference
From Exact Sciences Corp.
Via Business Wire
News headline image
Exact Sciences (EXAS) Q3 2025 Earnings Transcript ↗
Exact Sciences (EXAS) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Exact Sciences (NASDAQ:EXAS) Reports Upbeat Q3, Stock Soars
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year... 
Via StockStory
News headline image
Exact Sciences Flirts With A Breakout On Guidance Hike, Sales Beat ↗
Exact Sciences stock jumped late Monday on strong third-quarter sales, despite continued losses. The company raised its sales guide. 
Via Investor's Business Daily
Topics Earnings
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Exact Sciences Announces Third Quarter 2025 Results
From Exact Sciences Corp.
Via Business Wire
News headline image
Should You Buy Exact Sciences Stock Before Nov. 3? ↗
The company's outlook is improving as its innovative ways continue to pay off. 
Via The Motley Fool
News headline image
Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday? ↗
Wall Street opened the week on a mixed note on Monday. 
Via Benzinga
News headline image
Exact Sciences (EXAS) Reports Q3: Everything You Need To Know Ahead Of Earnings
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be announcing earnings results this Monday after market hours. Here’s what to expect. 
Via StockStory
News headline image
3 Unprofitable Stocks with Questionable Fundamentals
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
News headline image
3 Cash-Producing Stocks We Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
News headline image
Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps
From Exact Sciences Corp.
Via Business Wire
News headline image
11 Analysts Have This To Say About Exact Sciences ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.